Coronavirus (COVID-19) Update - We are reopening slowly while keeping your safety in mind.
Click here to learn more.
This is a phase 1 first-in-human clinical trial to assess the safety, tolerability, and immunogenicity of eOD-GT8 60mer Vaccine, Adjuvanted, in up to 48 healthy adult HIV-negative volunteers.
International AIDS Vaccine Initiative
David Diemert, MD/Medicine